Day: September 5, 2022

Dimensional Fund Advisors Ltd. : Form 8.3 - GO-AHEAD GROUP PLC - Ordinary Shares

Dimensional Fund Advisors Ltd. : Form 8.3 – GO-AHEAD GROUP PLC – Ordinary Shares

Written by Customer Service on . Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser:   Dimensional Fund Advisors Ltd. (“Dimensional”), in its capacity as investment manager and on behalf its affiliates who are also investment managers. Dimensional and its affiliates expressly disclaim beneficial ownership of the shares described in this form 8.3 (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.     (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate...

Continue reading

Dimensional Fund Advisors Ltd. : Form 8.3 - EUROMONEY INSTITUTIONAL INVESTOR PLC - Ordinary Shares

Dimensional Fund Advisors Ltd. : Form 8.3 – EUROMONEY INSTITUTIONAL INVESTOR PLC – Ordinary Shares

Written by Customer Service on . Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser:   Dimensional Fund Advisors Ltd. (“Dimensional”), in its capacity as investment manager and on behalf its affiliates who are also investment managers. Dimensional and its affiliates expressly disclaim beneficial ownership of the shares described in this form 8.3 (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.     (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate...

Continue reading

Dermal Fillers Market Size to Hit USD 8.74 billion by 2029

Dermal Fillers Market Size to Hit USD 8.74 billion by 2029

Written by Customer Service on . Posted in Mergers And Acquisitions.

According to Fortune Business Insights™, the global Dermal Fillers Market size is expected to reach USD 8.74 billion by 2029, at a CAGR of 7.4% during the forecast period, 2022-2029 Pune, India, Sept. 05, 2022 (GLOBE NEWSWIRE) — The Dermal Fillers Market was USD 5.05 billion in 2021 and is projected to grow from USD 5.31 billion in 2022 to USD 8.74 billion by 2029, exhibiting a CAGR of 7.4% during the forecast period. Fortune Business Insights™, provide this information in its latest report titled, “Dermal Fillers Market Forecast, 2022-2029.” Dermal fillers are products used to improve the appearance of skin. They are available in a variety of shapes and sizes, and can be filled with a variety of substances. Dermal fillers are used to improve the appearance of wrinkles, scars, and other skin issues. Industry Development March...

Continue reading

Dimensional Fund Advisors Ltd. : Form 8.3 - EMIS GROUP PLC - Ordinary Shares

Dimensional Fund Advisors Ltd. : Form 8.3 – EMIS GROUP PLC – Ordinary Shares

Written by Customer Service on . Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser:   Dimensional Fund Advisors Ltd. (“Dimensional”), in its capacity as investment manager and on behalf its affiliates who are also investment managers. Dimensional and its affiliates expressly disclaim beneficial ownership of the shares described in this form 8.3 (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.     (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate...

Continue reading

Dimensional Fund Advisors Ltd. : Form 8.3 - VISTRY GROUP PLC - Ordinary Shares

Dimensional Fund Advisors Ltd. : Form 8.3 – VISTRY GROUP PLC – Ordinary Shares

Written by Customer Service on . Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser:   Dimensional Fund Advisors Ltd. (“Dimensional”), in its capacity as investment manager and on behalf its affiliates who are also investment managers. Dimensional and its affiliates expressly disclaim beneficial ownership of the shares described in this form 8.3 (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.     (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate...

Continue reading

With 10.3% CAGR, Competitive Intelligence Tools Market Size to Reach USD 82.0 Billion [2022-2027]

With 10.3% CAGR, Competitive Intelligence Tools Market Size to Reach USD 82.0 Billion [2022-2027]

Written by Customer Service on . Posted in Mergers And Acquisitions.

According to Fortune Business Insights, the global Competitive Intelligence Tools Market Size is projected to hit USD 82.0 Billion in 2027, at CAGR of 10.3% during forecast period [2022-2027]; Competitive Intelligence Tools Industry to Develop Fundamentally; Growing Popularity of AI-powered Competitive Tools to Foster Growth, Pune, India, Sept. 05, 2022 (GLOBE NEWSWIRE) — The global competitive intelligence tools market size is expected to reach USD 82.0 million by 2027, exhibiting a CAGR of 10.3% during the forecast period [2022 – 2027].  The digital transformation coupled with heavy investment in analytics by companies can have an incredible effect on the global market, states Fortune Business Insights, in a report, titled “Competitive Intelligence Tools Market Size, Share &COVID-19 Impact Analysis, By Type, By Application,...

Continue reading

Progressive Cavity Pump Market Size Worth USD 7.09 Billion, Globally, by 2028 at 5.8% CAGR

Progressive Cavity Pump Market Size Worth USD 7.09 Billion, Globally, by 2028 at 5.8% CAGR

Written by Customer Service on . Posted in Mergers And Acquisitions.

The progressive cavity pump market size is expected to grow from USD 4.77 billion in 2021 to USD 7.09 billion by 2028; it is estimated to grow at a CAGR of 5.8% from 2021 to 2028. Pune, India, Sept. 05, 2022 (GLOBE NEWSWIRE) — The global progressive cavity pump market size was USD 4.45 billion in 2020. The market is projected to grow from USD 4.77 billion in 2021 to USD 7.09 billion in 2028 at a CAGR of 5.8% during the 2021-2028 period. This information is provided by Fortune Business Insights, in its report titled, “Progressive Cavity Pump Market, 2021-2028.” According to our researchers, rotating positive displacement pumps are the most common type of progressing cavity pump. They are mostly utilized for continuous, gentle conveyance and precise dosage due to their high process liability and suction capacity. They are incredibly...

Continue reading

Detailed planning for the next stage of Kodulahe has been initiated

Detailed planning for the next stage of Kodulahe has been initiated

Written by Customer Service on . Posted in Public Companies.

On 31.08.2022, the Tallinn City Government initiated the detailed planning of the plot belonging to Arco Vara subsidiary Kodulahe II OÜ, located at Soodi 6. The purpose of the detailed plan is to assign building rights to the property with a land area of 1.42 hectares: for the construction of up to three apartment buildings with partly commercial spaces, one underground and up to five above-ground floors. CEO of Arco Vara Miko Niinemäe’s comment: “The building on the Paldiski road side of the property will be with 5 above groud floors, the houses towards the sea side will remain with four floors. This time, too, we will stick to our principle that a high-quality living environment is the most important factor in real estate development – in the new phase there will be a total of about 75 apartments, so on average only...

Continue reading

Composition of Aspocomp’s Shareholders’ Nomination Board

Composition of Aspocomp’s Shareholders’ Nomination Board

Written by Customer Service on . Posted in Public Companies.

Aspocomp Group Plc, Stock Exchange Release, September 5, 2022 at 1:40 p.m. EEST Aspocomp Group Plc’s Annual General meeting on April 26, 2022 resolved to establish a Shareholders’ Nomination Board. The Nomination Board is responsible for preparing and presenting to the Annual General Meeting and, where appropriate, to the Extraordinary General Meeting, proposals regarding the number and remuneration of the members of the Board of Directors as well as a proposal regarding its composition. The Nomination Board comprises three members of whom each of the company’s three largest shareholders is entitled to appoint one member. In addition, the Chairman of the company’s Board of Directors shall serve as an expert member of the Nomination Board unless he or she is appointed as an ordinary member of the Board. The company’s largest shareholders...

Continue reading

Alvotech Reports Update on Initial AVT02 Biologics License Application

Alvotech Reports Update on Initial AVT02 Biologics License Application

Written by Customer Service on . Posted in Public Companies.

REYKJAVIK, Iceland, Sept. 05, 2022 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that Alvotech received communication from the U.S. Food and Drug Administration (FDA) detailing its assessment of the March 2022 inspection of Alvotech’s manufacturing facility in Reykjavik, Iceland and Alvotech’s subsequent written responses to the FDA. The FDA’s Complete Response Letter to the initial biosimilar Biologics License Application (BLA) for AVT02 noted certain deficiencies related to the Reykjavik facility and stated that satisfactory resolution of the deficiencies is required before FDA may approve this BLA.   “Alvotech looks forward to addressing the deficiencies outlined in the post-application action...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.